SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950170-22-000764
Filing Date
2022-02-04
Accepted
2022-02-04 09:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D haurwitz_schedule_13d_12.htm SC 13D 158350
  Complete submission text file 0000950170-22-000764.txt   159632
Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Subject) CIK: 0001619856 (see all company filings)

IRS No.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92726 | Film No.: 22591147
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CARIBOU BIOSCIENCES, INC. 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address
Haurwitz Rachel E. (Filed by) CIK: 0001670579 (see all company filings)

Type: SC 13D